These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16079640)

  • 21. Difference in early effects of statin therapy on coronary and forearm flow reserve in postmenopausal hypercholesterolemic women.
    Yoshihisa A; Iwai-Takano M; Yaoita H; Watanabe T; Maruyama Y
    Circ J; 2007 Jun; 71(6):954-61. PubMed ID: 17526996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of plasma cholesterol reduction by pravastatin on the functional properties of forearm arteries in hypercholesterolemic patients.
    Baldassarre D; Busnach G; Amato M; Pazzucconi F; Sirtori CR
    Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):108-17. PubMed ID: 10464783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
    John S; Schneider MP; Delles C; Jacobi J; Schmieder RE
    Am Heart J; 2005 Mar; 149(3):473. PubMed ID: 15864218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
    JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients.
    Inoue T; Hayashi M; Takayanagi K; Morooka S
    Atherosclerosis; 2002 Feb; 160(2):369-76. PubMed ID: 11849660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial function in the forearm circulation of patients with the metabolic syndrome--effect of different lipid-lowering regimens.
    Bulut D; Hanefeld C; Bulut-Streich N; Graf C; Mügge A; Spiecker M
    Cardiology; 2005; 104(4):176-80. PubMed ID: 16155389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial.
    Dupuis J; Tardif JC; Cernacek P; Théroux P
    Circulation; 1999 Jun; 99(25):3227-33. PubMed ID: 10385495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
    Arntz HR; Agrawal R; Wunderlich W; Schnitzer L; Stern R; Fischer F; Schultheiss HP
    Am J Cardiol; 2000 Dec; 86(12):1293-8. PubMed ID: 11113401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional evaluation of lipid-lowering therapy by pravastatin.
    Schoebel FC; Jax TW; Strauer BE; Leschke M
    Circulation; 1998 May; 97(18):1874-5. PubMed ID: 9603548
    [No Abstract]   [Full Text] [Related]  

  • 30. Vasodilatory capacity of forearm resistance vessels is augmented in hypercholesterolemic patients after treatment with fluvastatin.
    Schobel HP; Schmieder RE
    Angiology; 1998 Sep; 49(9):743-8. PubMed ID: 9756426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease.
    Duan C; Du ZD; Wang Y; Jia LQ
    World J Pediatr; 2014 Aug; 10(3):232-7. PubMed ID: 25124974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.
    LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease)
    Lancet; 2002 Apr; 359(9315):1379-87. PubMed ID: 11978335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of exercise training on vascular endothelial function in patients with stable coronary artery disease: a randomized controlled trial.
    Luk TH; Dai YL; Siu CW; Yiu KH; Chan HT; Lee SW; Li SW; Fong B; Wong WK; Tam S; Lau CP; Tse HF
    Eur J Prev Cardiol; 2012 Aug; 19(4):830-9. PubMed ID: 21724681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefits of statin treatment in cardiac syndrome-X1.
    Kayikcioglu M; Payzin S; Yavuzgil O; Kultursay H; Can LH; Soydan I
    Eur Heart J; 2003 Nov; 24(22):1999-2005. PubMed ID: 14613735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term withdrawal of simvastatin induces endothelial dysfunction in patients with coronary artery disease: a dose-response effect dependent on endothelial nitric oxide synthase.
    Chen H; Ren JY; Xing Y; Zhang WL; Liu X; Wu P; Wang RJ; Luo Y
    Int J Cardiol; 2009 Jan; 131(3):313-20. PubMed ID: 18221806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of oral beraprost sodium, a prostaglandin I2 analogue, on endothelium dependent vasodilatation in the forearm of patients with coronary artery disease.
    Ohata S; Ishibashi Y; Shimada T; Takahashi N; Sugamori T; Sakane T; Hirano Y; Oyake N; Murakami Y; Higami T
    Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):381-7. PubMed ID: 16620305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exercise training improves conduit vessel function in patients with coronary artery disease.
    Walsh JH; Bilsborough W; Maiorana A; Best M; O'Driscoll GJ; Taylor RR; Green DJ
    J Appl Physiol (1985); 2003 Jul; 95(1):20-5. PubMed ID: 12794092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation.
    Pitt B; Mancini GB; Ellis SG; Rosman HS; Park JS; McGovern ME
    J Am Coll Cardiol; 1995 Nov; 26(5):1133-9. PubMed ID: 7594023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease.
    Fichtlscherer S; Breuer S; Heeschen C; Dimmeler S; Zeiher AM
    J Am Coll Cardiol; 2004 Jul; 44(1):44-9. PubMed ID: 15234404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys.
    Williams JK; Sukhova GK; Herrington DM; Libby P
    J Am Coll Cardiol; 1998 Mar; 31(3):684-91. PubMed ID: 9502654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.